InsiderTrades

Form 4 for ELV Elevance Health

Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001156039-25-000022 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-03-05 2025-03-03 ELV BOUDREAUX GAIL Pres, CEO, Dir A - Grant $0.00 +26.2K 142.5K +23% $0
D 2025-03-05 2025-03-03 ELV BOUDREAUX GAIL Pres, CEO, Dir F - Tax $395.50 -10.4K 116.3K -8% -$4.11M
D 2025-03-05 2025-03-03 ELV BOUDREAUX GAIL Pres, CEO, Dir A - Grant $0.00 +40.4K 40.4K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-03 A A 10,620 $0.00 126,933 D — — (F2) Represents restricted share units. Restrictions lapse as follows: 3,540 shares on 3/3/2026, 3/3/2027 and 3/3/2028.
2 Common Common Stock 2025-03-03 A A 15,587 $0.00 142,520 D — — (F3) Represents performance based restricted share units. Restrictions lapse on 3/3/2025.
3 Common Common Stock 2025-03-03 F D 10,396 $395.50 116,313 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
4 Derivative Employee Stock Option (Right to Buy) 2025-03-03 A A 40,429 $0.00 40,429 D $395.50 · — to 2035-03-03 40,429 Common Stock (F4) The option represents a right to purchase a total of 40,429 shares, and is exercisable in three annual installments, with two installments of 13,476 shares each and one installment of 13,477 shares, beginning on 3/3/2026, which is the one-year anniversary of the option grant date.